Voices

Aug 19, 2025, 02:37

From Start to Finish, it’s About Collaboration – ENGOT

ENGOT shared a post on LinkedIn:

“What makes an ENGOT trial unique? From start to finish, it’s about collaboration:

ENGOT brings together researchers from 21 groups across 33 countries to run clinical trials designed to address the most pressing challenges facing gynaecological oncology today. This collaborative model ensures our trials are scientifically rigorous and robust – and, above all, relevant to patients in Europe and beyond.

ENGOT, being a research network of the European Society of Gynaecological Oncology (ESGO) and alongside the European Network of Gynaecological Cancer Advocacy Groups (ESGO ENGAGe), we work together to ensure our research professionals and patients are supported, with engagement and equity, throughout the trial process.

Explore our website to learn more about our research groups, information about gynaecological cancers, ongoing clinical trials and more.”

More posts featuring European Society of Gynaecological Oncology.

cancer ENGOT ESGO ESGO ENGAGe European Network of Gynaecological Cancer Advocacy Groups European Society of Gynaecological Oncology OncoDaily Oncology

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth